Filter posts

You’re Invited: BIO Board Member to Discuss Challenges Facing Emerging Biotechs – and How to Fix...

Next week, MaxCyte CEO and Biotechnology Innovation Organization (BIO) Board Member Doug Doerfler will speak …

Patents Are The Lifeblood of Biotechnology

Strong patents are the lifeblood of the biotechnology industry. They are critical in ensuring a …

Reps. Upton and Dingell on Solving America's Opioid Crisis

Writing this morning for the Detroit Free Press, Reps. Fred Upton (R-MI) and Debbie Dingell (D-MI) …

Important South Dakota Biologics Substitution Bill Heads to Governor's Desk

One of BIO’s top priorities is passage of state laws that establish consistent standards for …

BIO’S Spring IPCC Conference Registration is Now OPEN! With Special Offer for First Time In-House ...

Pack your bags patent practitioners – We’re heading back to the French Quarter. Registration for BIO’s …

The Value of Academic-Industry Partnerships

More than a decade ago, the NIH Roadmap and the FDA Critical Path Report brought significant public …

Former Senator Kyl: Abuse of the Patent Review Hurts American Innovation

Earlier this week The Hill ran an op-ed by Former Arizona Senator Jon Kyl in …

#BIF17: Turning the Tide on Antimicrobial Resistance

It’s no secret that antimicrobial resistance (AMR) is one of the most serious public health …

BIO to Senate Judiciary: Stop Abuses at PTO

Gamesmanship of the United States Patent and Trademark Office’s (PTO) Inter Partes Review (IPR) process …

Double Jeopardy at the PTO Threatens Healthcare Innovation

There has been no shortage of commentary related to the efforts of Allergan to shield …